Insider sales at Teva (NYSE: TEVA) — 9,908 & 7,924 shares reported

Rhea-AI Filing Summary

Teva Pharmaceutical Industries submitted a Form 144 notice reporting proposed sales tied to recent vesting of stock awards. The filing lists vesting events on 03/04/2026 (11,363 shares) and 03/05/2026 (9,895 shares). It records two dispositions by Christine Fox: 9,908 shares on 03/04/2026 for $321,658.26 and 7,924 shares on 03/05/2026 for $250,940.40.

Key Figures

Proposed sale by Christine Fox (03/04/2026): 9,908 shares Proposed sale by Christine Fox (03/05/2026): 7,924 shares Vesting event (03/04/2026): 11,363 shares +2 more

5 metrics

Proposed sale by Christine Fox (03/04/2026) 9,908 shares Disposition reported on 03/04/2026 for $321,658.26

Proposed sale by Christine Fox (03/05/2026) 7,924 shares Disposition reported on 03/05/2026 for $250,940.40

Vesting event (03/04/2026) 11,363 shares Listed as "Vesting of a Stock Award" on 03/04/2026 (Compensatory Payment)

Vesting event (03/05/2026) 9,895 shares Listed as "Vesting of a Stock Award" on 03/05/2026 (Compensatory Payment)

Securities information date and ledger 1,164,426,972 shares Figure shown with date 04/30/2026 under securities information

Key Terms

Form 144, Vesting of a Stock Award, Compensatory Payment, Selling Broker

4 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Vesting of a Stock Award financial

"03/04/2026 | Vesting of a Stock Award"

Compensatory Payment financial

"03/04/2026 | Compensatory Payment"

Selling Broker market

"Common | Merrill Lynch 3455 Peachtree Road NE"

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 3455 Peachtree Road NE Suite 1000 Atlanta GA 30326	21258	750633.14	1164426972	04/30/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/04/2026	Vesting of a Stock Award	Teva Pharmaceutical Industries			11363	03/04/2026	Compensatory Payment
Common	03/05/2026	Vesting of a Stock Award	Teva Pharmaceutical Industries			9895	03/05/2026	Compensatory Payment

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Christine Fox 400 Interpace Parkway, #3 Parsippany NJ 07054	Common	03/04/2026	9908	321658.26
Christine Fox 400 Interpace Parkway, #3 Parsippany NJ 07054	Common	03/05/2026	7924	250940.4

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does TEVA's Form 144 report about Christine Fox's transactions?

The Form 144 reports Christine Fox offered 9,908 shares on 03/04/2026 for $321,658.26 and 7,924 shares on 03/05/2026 for $250,940.40. These sales are linked to recent vesting events.

Were the reported shares related to compensation at TEVA?

Yes. The filing ties the transactions to vesting of a stock award described as a Compensatory Payment on 03/04/2026 and 03/05/2026 involving 11,363 and 9,895 shares respectively.

Which broker or dealer is listed in the Form 144 for TEVA?

The Form 144 lists Merrill Lynch at 3455 Peachtree Road NE, Atlanta, GA as the broker/dealer associated with the securities to be sold, and indicates NYSE as the market.

Does the Form 144 show TEVA's shares outstanding?

The excerpt includes a figure of 1,164,426,972 shares with a date of 04/30/2026, which appears under securities information and may reflect outstanding shares as of that date.

Are the proceeds from these transactions paid to TEVA or to the selling holder?

The filing shows cash amounts received for the reported dispositions by the selling holder ($321,658.26 and $250,940.40); it does not state that TEVA receives proceeds, indicating these are holder sales.